Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aniek van den Bosch

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 24, 2011
Tight control of STAT5 activity determines human CD34-derived interstitial dendritic cell and langerhans cell developmentLianne van de Laar, Aniek van den Bosch, Albertus T J Wierenga, et al.
Journal of Viral Hepatitis|May 16, 2019
Elevated serum levels of soluble CD14 in HBeAg-positive chronic HBV patients upon Peginterferon treatment are associated with treatment responseYingying Dou, Nadine van Montfoort, Aniek van den Bosch, et al.
Blood|October 24, 2012
PI3K-PKB hyperactivation augments human plasmacytoid dendritic cell development and functionLianne van de Laar, Aniek van den Bosch, André Boonstra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2010
A nonredundant role for canonical NF-κB in human myeloid dendritic cell development and functionLianne van de Laar, Aniek van den Bosch, Sandra W van der Kooij, et al.
Journal of Virology|April 22, 2016
Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent MechanismNadine van Montfoort, Evelyn van der Aa, Aniek van den Bosch, et al.
The Journal of Infectious Diseases|December 9, 2017
HBV-Derived Synthetic Long Peptide Can Boost CD4+ and CD8+ T-Cell Responses in Chronic HBV Patients Ex VivoYingying Dou, Nadine van Montfoort, Aniek van den Bosch, et al.
Antiviral Research|February 22, 2020
Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patientsYingying Dou, Diahann T S L Jansen, Aniek van den Bosch, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|May 24, 2011
Tight control of STAT5 activity determines human CD34-derived interstitial dendritic cell and langerhans cell developmentLianne van de Laar, Aniek van den Bosch, Albertus T J Wierenga, et al.
Journal of Viral Hepatitis|May 16, 2019
Elevated serum levels of soluble CD14 in HBeAg-positive chronic HBV patients upon Peginterferon treatment are associated with treatment responseYingying Dou, Nadine van Montfoort, Aniek van den Bosch, et al.
Blood|October 24, 2012
PI3K-PKB hyperactivation augments human plasmacytoid dendritic cell development and functionLianne van de Laar, Aniek van den Bosch, André Boonstra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2010
A nonredundant role for canonical NF-κB in human myeloid dendritic cell development and functionLianne van de Laar, Aniek van den Bosch, Sandra W van der Kooij, et al.
Journal of Virology|April 22, 2016
Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent MechanismNadine van Montfoort, Evelyn van der Aa, Aniek van den Bosch, et al.
The Journal of Infectious Diseases|December 9, 2017
HBV-Derived Synthetic Long Peptide Can Boost CD4+ and CD8+ T-Cell Responses in Chronic HBV Patients Ex VivoYingying Dou, Nadine van Montfoort, Aniek van den Bosch, et al.
Antiviral Research|February 22, 2020
Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patientsYingying Dou, Diahann T S L Jansen, Aniek van den Bosch, et al.
Pageof 1